Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SHR-1139 injection in adults with palmoplantar pustulosis
ChiCTR2600135972Phase 2Not yet recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Jul 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SHR-1139 in Palmoplantar Pustular Psoriasis (PPPP) (2 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Palmoplantar Pustulosis Area and Severity Index. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
SHR-1139
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on ChiCTR2600135972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135972.